MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

Search

Nektar Therapeutics

Closed

57.25 4.3

Overview

Share price change

24h

Current

Min

54.7

Max

63.04

Key metrics

By Trading Economics

Income

9.3M

-42M

Sales

715K

11M

EPS

-2.78

Profit margin

-372.197

Employees

61

EBITDA

4.7M

-36M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+83.72% upside

Dividends

By Dow Jones

Next Earnings

6 lis 2025

Market Stats

By TradingEconomics

Market Cap

688M

1.1B

Previous open

52.95

Previous close

57.25

Technical Score

By Trading Central

Confidence

Strong Bearish Evidence

Nektar Therapeutics Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

16 paź 2025, 21:10 UTC

Major Market Movers

Kezar Life Sciences Shares Surge After Break with FDA, Restructuring Plan

16 paź 2025, 19:03 UTC

Acquisitions, Mergers, Takeovers

Canada Signals Limited Concern Over U.S. Government Stakes in Canadian Miners -- 2nd Update

16 paź 2025, 17:58 UTC

Acquisitions, Mergers, Takeovers

Canada Signals Limited Concern Over U.S. Government Stakes in Canadian Miners -- Update

16 paź 2025, 17:12 UTC

Earnings

Ray-Ban Maker EssilorLuxottica's Revenue Surges to Quarterly Record -- Update

16 paź 2025, 17:12 UTC

Acquisitions, Mergers, Takeovers

Canada Signals Limited Concern Over US Government Stakes in Canadian Miners

16 paź 2025, 16:59 UTC

Acquisitions, Mergers, Takeovers

Airbus's Takeover of Spirit AeroSystems Plants Gets French Antitrust Clearance

16 paź 2025, 23:44 UTC

Market Talk

Gold Climbs Amid Safe-Haven Demand -- Market Talk

16 paź 2025, 23:42 UTC

Market Talk

Nikkei May Fall, Tracking Wall Street's Declines -- Market Talk

16 paź 2025, 23:42 UTC

Market Talk

Global Equities Roundup: Market Talk

16 paź 2025, 22:15 UTC

Earnings

China Tower: Results Supported by Higher Contributions From Energy, Smart Tower Business >0788.HK

16 paź 2025, 22:15 UTC

Earnings

China Tower 9-Mos Rev CNY74.32B Vs. CNY72.45B >0788.HK

16 paź 2025, 22:15 UTC

Earnings

China Tower 9-Mos Net CNY8.71B Vs. Net CNY8.15B >0788.HK

16 paź 2025, 22:02 UTC

Market Talk

Global Equities Roundup: Market Talk

16 paź 2025, 22:02 UTC

Market Talk

Santos Drifts Into 'Oversold Territory' -- Market Talk

16 paź 2025, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

16 paź 2025, 20:50 UTC

Market Talk
Earnings

Health Care Roundup: Market Talk

16 paź 2025, 20:23 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

16 paź 2025, 20:23 UTC

Market Talk

Recession Risks to Push Canada Toward October Rate Cut -- Market Talk

16 paź 2025, 20:20 UTC

Earnings

These Stocks Moved the Most Today: TSMC, Salesforce, HPE, F5, United Airlines, Travelers, J.B. Hunt, Praxis Precision, and More -- Barrons.com

16 paź 2025, 20:08 UTC

Acquisitions, Mergers, Takeovers

Jack in the Box to Sell Del Taco With Big Markdown. The Stock Plunged. -- Barrons.com

16 paź 2025, 19:37 UTC

Acquisitions, Mergers, Takeovers

Crypto Industry Dives Deeper Into Prediction Markets as Kraken Buys Exchange -- Barrons.com

16 paź 2025, 19:26 UTC

Earnings

Oracle Weighs In on Cloud Margins. The Stock Is Rising. -- Barrons.com

16 paź 2025, 19:24 UTC

Market Talk

U.S. Natural Gas Falls on Mild Weather, Ample Storage -- Market Talk

16 paź 2025, 19:23 UTC

Market Talk

Oil Falls As Oversupply Concerns Outweigh India News -- Market Talk

16 paź 2025, 19:23 UTC

Earnings

Oracle Weighs In on Cloud Margins. The Stock Is Rising. -- Barrons.com

16 paź 2025, 18:35 UTC

Market Talk
Earnings

Charles Schwab Logs Another Quarter of Record Revenues, Earnings -- Market Talk

16 paź 2025, 18:31 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

16 paź 2025, 18:31 UTC

Market Talk

Global Equities Roundup: Market Talk

16 paź 2025, 18:31 UTC

Market Talk

Charles Schwab Readies Spot Crypto Trading -- Market Talk

16 paź 2025, 16:57 UTC

Market Talk

Oil Futures Lose Ground as EIA Reports Crude Stock Build -- Market Talk

Peer Comparison

Price change

Nektar Therapeutics Forecast

Price Target

By TipRanks

83.72% upside

12 Months Forecast

Average 104.5 USD  83.72%

High 120 USD

Low 98 USD

Based on 8 Wall Street analysts offering 12 month price targets forNektar Therapeutics - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

8 ratings

6

Buy

1

Hold

1

Sell

Technical Score

By Trading Central

0.5949 / 0.7406Support & Resistance

Short Term

Strong Bearish Evidence

Intermediate Term

Strong Bearish Evidence

Long Term

Bearish Evidence

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

help-icon Live chat